Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications

被引:96
作者
Bornet, FRJ
Brouns, F
Tashiro, Y
Duvillier, V
机构
[1] NutriHlth SA, F-92500 Rueil Malmaison, France
[2] Sci Serv Grp, Vilvoorde, Belgium
[3] Maasricht Univ, Nutr & Toxicol Res Inst, Maastricht, Netherlands
[4] Meiji Seika Kaisha Ldt, Kawasaki, Kanagawa, Japan
[5] Beghin Beiji, Neuilly Sur Seine, France
关键词
bacteria; colon; short-chain fatty acid; short-chain fructooligosaccharides;
D O I
10.1016/S1590-8658(02)80177-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Short-chain fructooligosaccharides occur in a number of edible plants, such as chicory, onions, asparagus, wheat... They are a group of linear fructose oligomers with a degree of polymerisation ranging from n = I up to 5 (oligosaccharides). Short-chain fructooligosaccharides, to a large extent, escape digestion in the human upper intestine and reach the colon where they are totally fermented mostly to lactate, short chain fatty acids (acetate, propionate and butyrate), and gas, like dietary fibres. As a consequence of their fermentation, their caloric value is approximately 2 Kcal/g. A faecal bulking effect of fructooligosaccharides has been observed in humans. An important property of short-chain fructooligosaccharides is the stimulation of bifidobacterial growth specifically while suppressing the growth of potentially harmful species such as, for example, Clostridium perfringens in the colon. It is associated with a decrease in faecal pH, an increase in faecal or colonic organic acids, a decrease in the production of nitrogenous end products in urine and stools, a decrease in faecal bacterial enzymatic activities and a modification in faecal neutral sterols. The short-chain fructooligosaccharides enhance magnesium absorption in humans and have been shown, in animal models, to reduce colon tumour development by enhancing both colon butyrate concentrations and local immune system effectors.
引用
收藏
页码:S111 / S120
页数:10
相关论文
共 75 条
[1]  
ANDERSON JW, 1984, P SOC EXP BIOL MED, V177, P372
[2]  
[Anonymous], 1991, Bifidobacteria and Microflora
[3]  
[Anonymous], 1994, Bifidobacteria Microflora, DOI DOI 10.12938/BIFIDUS1982.13.2_79
[4]   NET HEPATIC AND SPLANCHNIC METABOLISM OF LACTATE, PYRUVATE AND PROPIONATE IN DAIRY-COWS INVIVO IN RELATION TO LACTATION AND NUTRIENT SUPPLY [J].
BAIRD, GD ;
LOMAX, MA ;
SYMONDS, HW ;
SHAW, SR .
BIOCHEMICAL JOURNAL, 1980, 186 (01) :47-57
[5]  
BALXTER K, 1989, ENERGY METABOLISM AN
[6]   Cytokine mRNA expression in mouse colon:: IL-15 mRNA is overexpressed and is highly sensitive to a fibre-like dietary component (short-chain fructo-oligosaccharides) in an Apc gene manner [J].
Bassonga, E ;
Forest, V ;
Pierre, F ;
Bornet, F ;
Perrin, P ;
Meflah, K ;
Menanteau, J .
CYTOKINE, 2001, 14 (04) :243-246
[7]   DIGESTION AND ABSORPTION IN THE HUMAN INTESTINE OF 3 SUGAR ALCOHOLS [J].
BEAUGERIE, L ;
FLOURIE, B ;
MARTEAU, P ;
PELLIER, P ;
FRANCHISSEUR, C ;
RAMBAUD, JC .
GASTROENTEROLOGY, 1990, 99 (03) :717-723
[8]  
BLAIR JB, 1973, J BIOL CHEM, V248, P3608
[9]   EFFECTS OF DIETARY PROPIONATE ON HEPATIC GLUCOSE-PRODUCTION, WHOLE-BODY GLUCOSE-UTILIZATION, CARBOHYDRATE AND LIPID-METABOLISM IN NORMAL RATS [J].
BOILLOT, J ;
ALAMOWITCH, C ;
BERGER, AM ;
LUO, J ;
BRUZZO, F ;
BORNET, FRJ ;
SLAMA, G .
BRITISH JOURNAL OF NUTRITION, 1995, 73 (02) :241-251
[10]  
BORNET FRJ, 1994, GUMS AND STABILIZERS FOR THE FOOD INDUSTRY 7, P217